Injectable medicine for children with heart failure
Part of Heart & circulation clinical trials.
This trial tests a medicine injected into the body that may help children with heart failure. It aims to see if it can improve how well the heart pumps blood, and it is done in a hospital setting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age: The patient must be under 18 years old.
- Heart condition: The patient must be in the hospital with a weak heart pump (ejection fraction below 55%).
- Consent: A parent or guardian must agree in writing, and the child may need to agree if old enough.
- No other serious heart issues, like dangerous rhythms or blockages from heart disease.
- No heart transplant or mechanical pump in the past, or planned within the next 3 months.
- No severe allergies (especially to the study drug or lactose), or major liver or kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment made from stem cells that are turned into heart muscle cells and injected directly into the heart. It is for people with advanced heart failure who are already on the best available medicines and who are scheduled to have bypass surgery.
This study tests an experimental medicine called NNC0537-1482 for people with heart failure. It aims to see if the medicine helps improve symptoms and heart function.
This trial tests whether injecting lab-grown heart cells into the heart can help people with heart failure whose heart pumps less than 40% of normal. It may help improve heart function and reduce symptoms.
This study tests a medicine called finerenone in children with heart failure. It looks at whether finerenone helps the heart work better and is safe compared to a placebo (a dummy pill), when taken with the usual heart-failure medicines.
This study tests an investigational medicine called EDG-15400 for people with a type of heart failure where the heart muscle is stiff and doesn't relax properly, even though the pumping function is normal. The goal is to see if the medicine improves symptoms and daily functioning.
This study compares two types of heart failure medicines, ARNI and ACE inhibitors, to see which works better for children with dilated cardiomyopathy (a weakened heart muscle that affects pumping). It may help improve heart function and quality of life in children.
Hear when a new Cardiac Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.